SPATA31E1: Potential Drug Target Or Biomarker (G286234)

Target Name: SPATA31E1

NCBI ID: G286234

SPATA31E1

SPATA31E1: Potential Drug Target Or Biomarker

SPATA31E1, also known as Protein FAM75E1, is a protein that is expressed in various tissues throughout the body. It is a member of the FAM75 family of proteins, which are known for their role in cell signaling and development. While SPATA31E1 has not yet been identified as a drug target or biomarker, it is possible that it may have future potential in these areas.

SPATA31E1 is a 21-kDa protein that is expressed in a variety of tissues, including muscle, heart, kidney, and brain. It is characterized by a N-terminal region that contains a putative N-acyltransferase (NAT) domain, as well as a C-terminal region that contains a putative G protein-coupled receptor (GPCR) domain. The N-terminal region of SPATA31E1 contains a characteristic Rossmann (尾) sheet, which is a common structural motif found in proteins that are involved in protein-protein interactions and other cellular processes.

SPATA31E1 is involved in a number of cellular processes that are important for normal development and function. For example, it has been shown to be involved in the regulation of cell adhesion, as well as the development and maintenance of neural circuits. It has also been shown to play a role in the regulation of ion channels and neurotransmitter release.

In addition to its role in cellular signaling, SPATA31E1 may also have potential as a drug target or biomarker. One way to identify potential drug targets is to use techniques such as yeast two-hybrid assays or protein fragment complementation assays to identify interacting proteins with known drug targets. SPATA31E1 has been shown to interact with a variety of protein partners, including the transcription factor, p53. This suggests that it may be a potential drug target for a variety of diseases.

Another way to identify potential biomarkers is to use techniques such as mass spectrometry or affinity purification to identify proteins that are associated with specific diseases or conditions. SPATA31E1 has been shown to be expressed in a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders. This suggests that it may be a potential biomarker for these conditions.

While SPATA31E1 is not yet identified as a drug target or biomarker, it is clear that it has potential in these areas. Further research is needed to fully understand its role in cellular signaling and its potential as a drug target or biomarker.

Protein Name: SPATA31 Subfamily E Member 1

Functions: May play a role in spermatogenesis

The "SPATA31E1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SPATA31E1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets